Grigorios Siokas Purchases 88,314 Shares of Cosmos Health (NASDAQ:COSM) Stock

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas purchased 88,314 shares of the firm’s stock in a transaction on Friday, December 19th. The shares were acquired at an average price of $0.49 per share, for a total transaction of $43,273.86. Following the purchase, the chief executive officer directly owned 6,716,771 shares of the company’s stock, valued at approximately $3,291,217.79. This represents a 1.33% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Grigorios Siokas also recently made the following trade(s):

• On Monday, December 15th, Grigorios Siokas acquired 168,472 shares of Cosmos Health stock. The shares were acquired at an average cost of $0.42 per share, with a total value of $70,758.24.
• On Friday, November 28th, Grigorios Siokas bought 76,360 shares of Cosmos Health stock. The shares were acquired at an average price of $0.64 per share, for a total transaction of $48,870.40.
• On Tuesday, November 25th, Grigorios Siokas bought 55,732 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.63 per share, for a total transaction of $35,111.16.
• On Friday, November 21st, Grigorios Siokas purchased 56,080 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.68 per share, with a total value of $38,134.40.
• On Thursday, November 20th, Grigorios Siokas acquired 51,315 shares of Cosmos Health stock. The shares were bought at an average cost of $0.62 per share, for a total transaction of $31,815.30.
• On Wednesday, November 19th, Grigorios Siokas acquired 61,614 shares of Cosmos Health stock. The stock was bought at an average price of $0.65 per share, for a total transaction of $40,049.10.

Cosmos Health Trading Down 1.9%

Shares of COSM opened at $0.52 on Wednesday. The company has a current ratio of 0.99, a quick ratio of 0.84 and a debt-to-equity ratio of 0.25. The stock has a market cap of $18.16 million, a PE ratio of -0.69 and a beta of 5.34. Cosmos Health Inc. has a 1 year low of $0.28 and a 1 year high of $1.32. The stock has a 50 day simple moving average of $0.70 and a 200-day simple moving average of $0.72.

Cosmos Health (NASDAQ:COSM) last announced its quarterly earnings results on Friday, November 14th. The company reported ($0.17) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.16). The company had revenue of $17.11 million during the quarter, compared to the consensus estimate of $16.40 million. Cosmos Health had a negative net margin of 31.01% and a negative return on equity of 33.19%. On average, sell-side analysts predict that Cosmos Health Inc. will post -0.78 EPS for the current fiscal year.

Institutional Investors Weigh In On Cosmos Health

A hedge fund recently raised its stake in Cosmos Health stock. Citadel Advisors LLC grew its stake in Cosmos Health Inc. (NASDAQ:COSM) by 133.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 225,507 shares of the company’s stock after acquiring an additional 128,776 shares during the period. Citadel Advisors LLC owned 0.65% of Cosmos Health worth $250,000 as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 12.61% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on COSM. Wall Street Zen upgraded shares of Cosmos Health to a “hold” rating in a research report on Saturday, September 20th. Weiss Ratings reissued a “sell (d-)” rating on shares of Cosmos Health in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the company currently has an average rating of “Sell”.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.